Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 0.00 | 250.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 250.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | 0.00 | 0.00 | 250.00K |
| SG&A Expenses | 5.80M | 6.06M | 6.27M | 6.12M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.86M | 14.41M | 14.59M | 13.99M | 13.10M |
| Operating Income | -14.86M | -14.41M | -14.59M | -13.99M | -12.85M |
| Income Before Tax | -14.44M | -14.07M | -14.17M | -13.49M | -12.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.44 | -14.07 | -14.17 | -13.49 | -12.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.44M | -14.07M | -14.17M | -13.49M | -12.30M |
| EBIT | -14.86M | -14.41M | -14.59M | -13.99M | -12.85M |
| EBITDA | -14.86M | -14.40M | -14.59M | -13.99M | -12.84M |
| EPS Basic | -11.78 | -15.05 | -20.10 | -24.71 | -28.25 |
| Normalized Basic EPS | -7.37 | -9.18 | -12.31 | -15.19 | -17.41 |
| EPS Diluted | -11.78 | -15.05 | -20.10 | -24.71 | -28.25 |
| Normalized Diluted EPS | -7.37 | -9.18 | -12.31 | -15.19 | -17.41 |
| Average Basic Shares Outstanding | 5.66M | 4.11M | 3.10M | 2.30M | 1.82M |
| Average Diluted Shares Outstanding | 5.66M | 4.11M | 3.10M | 2.30M | 1.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |